|
US6440421B1
(en)
|
1996-04-18 |
2002-08-27 |
Auchkland Uniservices Limited |
Treatment of bone disorders with adrenomedullin or adrenomedullin agonists
|
|
US5888963A
(en)
*
|
1996-04-18 |
1999-03-30 |
Auckland Uniservices Limited |
Treatment of bone disorders with adrenomedullin
|
|
AU9369098A
(en)
|
1997-09-26 |
1999-04-23 |
Auckland Uniservices Limited |
Therapeutic method
|
|
PT1214600E
(pt)
*
|
1999-09-10 |
2006-05-31 |
Us Gov Health & Human Serv |
Determinacao de proteinas de ligacao a adrenomedulina
|
|
KR100486622B1
(ko)
*
|
2000-11-17 |
2005-05-03 |
차국헌 |
폴리메틸실세스퀴옥산 공중합체와 그 제조방법 및 이를이용한 저유전성 코팅막
|
|
FR2821080B1
(fr)
*
|
2001-02-20 |
2003-12-19 |
Sanofi Synthelabo |
Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques
|
|
US20110087312A1
(en)
*
|
2001-03-02 |
2011-04-14 |
Erchonia Corporatin |
Method for Treatment of Diabetes and Prediabetes with Low-Level Laser Therapy
|
|
JP2005508838A
(ja)
|
2001-03-23 |
2005-04-07 |
アフトン コーポレーション |
膵癌の組合せ治療
|
|
US20090191232A1
(en)
|
2001-05-04 |
2009-07-30 |
Gevas Philip C |
Combination therapy for the treatment of tumors
|
|
AU2003221096A1
(en)
*
|
2002-03-19 |
2003-09-29 |
Oncorex, Inc. |
Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
|
|
US20040127445A1
(en)
*
|
2002-08-28 |
2004-07-01 |
Chondrogene Limited |
Beta-2 microglobulin (B2M) and B2M related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation
|
|
CA2500405A1
(en)
*
|
2002-09-30 |
2004-04-15 |
Oncotherapy Science, Inc. |
Genes and polypeptides relating to human myeloid leukemia
|
|
EP1575417A4
(en)
*
|
2002-09-30 |
2007-07-04 |
Bayer Pharmaceuticals Corp |
CANCER FORECASTING AND PROGNOSTIC TECHNIQUES AND SURVEILLANCE OF ANTICANCER THERAPY
|
|
EP1545287B1
(en)
|
2002-10-04 |
2012-12-05 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES |
Vasoregulating compounds and methods of their use
|
|
JP5068428B2
(ja)
*
|
2002-11-07 |
2012-11-07 |
アメリカ合衆国 |
血管新生および抗血管新生療法のための標的
|
|
JP4689597B2
(ja)
*
|
2003-03-28 |
2011-05-25 |
レセプター バイオロジックス インク． |
ガストリンホルモン免疫アッセイ
|
|
US7228658B2
(en)
|
2003-08-27 |
2007-06-12 |
Weyerhaeuser Company |
Method of attaching an end seal to manufactured seeds
|
|
US20080249115A1
(en)
*
|
2003-09-08 |
2008-10-09 |
The Government Of The United States Of America, As |
Non Peptide Agonists and Antagonists of Adrenomedullin and Gastric Releasing Peptide
|
|
US8691575B2
(en)
*
|
2003-09-30 |
2014-04-08 |
Weyerhaeuser Nr Company |
General method of classifying plant embryos using a generalized Lorenz-Bayes classifier
|
|
US20050108935A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system of manufacturing artificial seed coats
|
|
US7555865B2
(en)
*
|
2003-11-25 |
2009-07-07 |
Weyerhaeuser Nr Company |
Method and system of manufacturing artificial seed coats
|
|
CA2484533C
(en)
*
|
2003-11-25 |
2008-12-02 |
Weyerhaeuser Company |
Systems and method of embryo delivery for manufactured seeds
|
|
US20050108929A1
(en)
*
|
2003-11-25 |
2005-05-26 |
Edwin Hirahara |
Method and system for creating manufactured seeds
|
|
CA2486289C
(en)
*
|
2003-11-25 |
2008-01-08 |
Weyerhaeuser Company |
Combination end seal and restraint
|
|
US7356965B2
(en)
*
|
2003-12-11 |
2008-04-15 |
Weyerhaeuser Co. |
Multi-embryo manufactured seed
|
|
US7591287B2
(en)
*
|
2003-12-18 |
2009-09-22 |
Weyerhaeuser Nr Company |
System and method for filling a seedcoat with a liquid to a selected level
|
|
US7568309B2
(en)
*
|
2004-06-30 |
2009-08-04 |
Weyerhaeuser Nr Company |
Method and system for producing manufactured seeds
|
|
KR101333168B1
(ko)
|
2004-09-22 |
2013-11-28 |
리셉터 바이오로직스 인크 |
프로가스트린에 대한 모노클로날 항체
|
|
US20060070145A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Carlson William C |
Manufactured seed having a live end seal
|
|
US20060064930A1
(en)
*
|
2004-09-27 |
2006-03-30 |
Carlson William C |
Manufactured seed having a live end seal coating
|
|
US7547488B2
(en)
*
|
2004-12-15 |
2009-06-16 |
Weyerhaeuser Nr Company |
Oriented strand board panel having improved strand alignment and a method for making the same
|
|
US7654037B2
(en)
*
|
2005-06-30 |
2010-02-02 |
Weyerhaeuser Nr Company |
Method to improve plant somatic embryo germination from manufactured seed
|
|
US8168592B2
(en)
|
2005-10-21 |
2012-05-01 |
Amgen Inc. |
CGRP peptide antagonists and conjugates
|
|
US9829494B2
(en)
*
|
2005-12-01 |
2017-11-28 |
Adrenomed Ag |
Methods of treatment using ADM antibodies
|
|
US8906857B2
(en)
*
|
2005-12-01 |
2014-12-09 |
B.R.A.H.M.S. Gmbh |
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
|
|
DE102006052916A1
(de)
*
|
2006-11-08 |
2008-05-15 |
Brahms Aktiengesellschaft |
Diagnose und Risikostratifizierung von Diabetes mellitus mittels MR-proADM
|
|
EP2190533A2
(en)
*
|
2007-09-11 |
2010-06-02 |
Mondobiotech Laboratories AG |
Use of a peptide as a therapeutic agent
|
|
FR2934597B1
(fr)
*
|
2008-07-31 |
2013-04-19 |
Univ Aix Marseille Ii |
Anticorps se liant aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament.
|
|
WO2010049180A1
(en)
*
|
2008-10-31 |
2010-05-06 |
B.R.A.H.M.S. Ag |
Methods and assays for classifying foodstuff and/or beverage and/or diet and/or nutrition regimen and/or medicament in view of an effect on the cardiovascular system
|
|
CA2748314C
(en)
|
2009-02-03 |
2018-10-02 |
Amunix Operating Inc. |
Extended recombinant polypeptides and compositions comprising same
|
|
EP2389799A1
(en)
*
|
2010-05-25 |
2011-11-30 |
BioMass Booster, S.L. |
Method for increasing plant biomass
|
|
CN103109192A
(zh)
*
|
2010-06-18 |
2013-05-15 |
塞尚公司 |
用于妊娠性高血压和先兆子痫的预后和风险评估的标志物
|
|
FR2964103B1
(fr)
*
|
2010-08-30 |
2018-11-23 |
Universite D'aix-Marseille |
Anticorps se liant a l'adrenomedulline et aux recepteurs de l'adrenomedulline et leurs utilisations comme medicament
|
|
JP5932279B2
(ja)
*
|
2011-10-07 |
2016-06-08 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
US8776012B2
(en)
*
|
2011-10-25 |
2014-07-08 |
International Business Machines Corporation |
Automatic scheduling of review meetings
|
|
EP2780370B1
(en)
|
2011-11-16 |
2019-09-25 |
AdrenoMed AG |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
|
|
EP4086283A1
(en)
|
2011-11-16 |
2022-11-09 |
AdrenoMed AG |
Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
|
|
DK2780717T3
(en)
|
2011-11-16 |
2017-02-13 |
Sphingotec Gmbh |
ADRENOMEDULLINASSAYS AND METHODS FOR DETERMINING MODERN ADRENOMEDULLIN
|
|
DK2780371T3
(en)
|
2011-11-16 |
2019-02-25 |
Adrenomed Ag |
ANTI-ADDRENOMEDULLIN (ADM) ANTIBODY OR ANTI-ADM ANTISTOFFRAGMENT OR ANTI-ADM NON-IG TEMPLATE FOR REGULATING LIQUID BALANCE OF A PATIENT WITH A CHRONIC OR ACUTE DISEASE
|
|
JP5953108B2
(ja)
*
|
2012-05-14 |
2016-07-20 |
ポーラ化成工業株式会社 |
スクリーニング方法
|
|
EP2905029B1
(en)
|
2012-10-04 |
2018-11-21 |
Shionogi&Co., Ltd. |
Drug for inhibiting malignant tumor metastasis
|
|
WO2015092021A1
(en)
*
|
2013-12-20 |
2015-06-25 |
Spingotec Therapeutics Gmbh |
Adrenomedullin binder for use in therapy of cancer
|
|
PT3067093T
(pt)
*
|
2015-03-12 |
2019-11-18 |
Fund Rioja Salud |
Utilização de um inibidor de adrenomedulina para a produção de um fármaco útil na prevenção e tratamento de doenças que reduzem a densidade óssea
|
|
CA3064962A1
(en)
|
2017-05-26 |
2018-11-29 |
National Research Council Of Canada |
Self-assembling peptide for activating human mast cells
|
|
WO2018232230A1
(en)
|
2017-06-15 |
2018-12-20 |
Cancer Advances Inc. |
Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
|
|
US12150978B2
(en)
|
2017-06-15 |
2024-11-26 |
Cancer Advances Inc. |
Compositions and methods for preventing tumors and cancer
|
|
EP3438668A1
(en)
*
|
2017-08-04 |
2019-02-06 |
B.R.A.H.M.S GmbH |
Diagnosis and risk stratification of fungal infections
|
|
EP3971572A1
(en)
|
2017-09-13 |
2022-03-23 |
B.R.A.H.M.S GmbH |
Proadrenomedullin as a marker for abnormal platelet levels
|
|
WO2019053116A1
(en)
|
2017-09-13 |
2019-03-21 |
B.R.A.H.M.S Gmbh |
FLUID THERAPY GUIDING METHOD BASED ON PROADRENOMEDULLINE
|
|
EP3502706A1
(en)
|
2017-12-20 |
2019-06-26 |
B.R.A.H.M.S GmbH |
Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin
|
|
EP3578989A1
(en)
|
2018-06-06 |
2019-12-11 |
B.R.A.H.M.S GmbH |
Pro-adm for prognosis of trauma-related complications in polytrauma patients
|
|
CN115175920B
(zh)
|
2019-11-13 |
2025-10-31 |
阿穆尼克斯制药公司 |
加条形码的xten多肽及其组合物以及其制备和使用方法
|